Watch / Small Cap

Control Bionics jumping towards record revenue

17 June 20255:10

Control Bionics jumping towards record revenue

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Jeremy Steele, CEO of Control Bionics (ASX:CBL) provides a trading update, showing a 14% revenue increase to nearly $5.5 million. He says the company focuses on EMG technology to aid communication for patients with conditions like motor neurone disease, ALS, and cerebral palsy.

Jeremy states the firm is innovating with products like the Neuro Node and Neuro Strip, offering new opportunities in sports, rehabilitation, and hospital environments. Control Bionics' (ASX:CBL) autonomous wheelchair, Drover, aims to improve independence for people with mobility challenges.

The company focuses on growth in the US and Europe, securing new distribution agreements. Jeremy notes opportunities in the UK's NHS, aiming for financial growth and stock recovery amid challenging biotech market conditions.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy